ERTUMAXOMAB
| Drug Type | Action Type | Mechanism of Action | Approved | Max Trial Phase | Max GBM Phase |
|---|---|---|---|---|---|
| Antibody | CROSS-LINKING AGENT | T-cell surface glycoprotein CD3 epsilon chain cross-linking agent | no | 2 | 0 |
| Drug Type | Action Type | Mechanism of Action | Approved | Max Trial Phase | Max GBM Phase |
|---|---|---|---|---|---|
| Antibody | CROSS-LINKING AGENT | T-cell surface glycoprotein CD3 epsilon chain cross-linking agent | no | 2 | 0 |